Certified by Founder Lodge
Marea Therapeutics
United States - San Francisco, CA
START UP
1 Disclosed Funding Rounds $190,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 20 ,2024 | Series A | $190,000,000 |
Alpha Wave Global, LP
Omega Funds
Third Rock Ventures
Forbion
Sofinnova Investments
Surveyor Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Fabriclore | $1,600,000 | (Jul 2, 2024)
Waypoint Bio | $14,500,000 | (Jul 2, 2024)
K Health | $50,000,000 | (Jul 2, 2024)
Vytal | The reuse system | $6,644,850 | (Jul 2, 2024)
Pieces for Developers | $13,500,000 | (Jul 2, 2024)
